Cambridge, United Kingdom

Alexander Redvers Eberlin

USPTO Granted Patents = 7 


 

Average Co-Inventor Count = 4.9

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2010-2016

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Sure, here is the article about inventor Alexander Redvers Eberlin as per the given data:

Title: Alexander Redvers Eberlin - The Innovator from Cambridge

Introduction:

Alexander Redvers Eberlin, a prominent inventor based in Cambridge, GB, has made significant contributions to the field of pharmaceuticals through his innovative patents. With a total of 7 patents to his name, Eberlin is recognized for his groundbreaking work in developing novel chemical compounds to combat various diseases.

Latest Patents:

Eberlin's latest patents showcase his expertise in creating salts and solid forms of isoquinolinones that modulate kinase activity, particularly PI3 kinase activity. These compounds, along with their pharmaceutical compositions, offer new methods for treating diseases associated with kinase activity. Additionally, Eberlin has introduced processes for preparing these compounds and pharmaceutical compositions, demonstrating his commitment to advancing medical solutions.

Career Highlights:

During his career, Eberlin has been associated with esteemed companies such as Spinifex Pharmaceuticals Pty Ltd, where he honed his skills and expertise in pharmaceutical research and development. His innovative approach to drug discovery has led to the successful filing of multiple patents, establishing him as a key player in the pharmaceutical industry.

Collaborations:

Throughout his journey, Eberlin has collaborated with talented individuals in the field, including Thomas David McCarthy and Craig James Stewart Boyle. These collaborations have not only fostered innovation but also enabled Eberlin to exchange ideas and knowledge with fellow experts, further enhancing his contributions to the industry.

Conclusion:

In conclusion, Alexander Redvers Eberlin's dedication to pioneering novel pharmaceutical compounds is evident through his remarkable patents and career achievements. His inventive spirit and collaborative efforts have positioned him as a leading figure in the realm of drug discovery, with the potential to continue making significant strides in improving healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…